

# Event Details

- **Event Name**: GenScript Biotech Global Forum London 2025
- **Event Start and End Date**: Thu, 20 Nov, 2025 at 01:30 pm – Thu, 20 Nov, 2025 at 06:30 pm
- **Event Description**: The Forum unites CGT leaders to turn breakthroughs into patient value, bridging science, industry, and capital markets.About this Event(1) GenScript Biotech Global Forum London 2025The field of gene and cell therapy is experiencing unprecedented growth, driven by groundbreaking innovations in life sciences, medicine, and robust investment from global capital markets. To foster progress in this transformative field, the GenScript Biotech Global Forum London 2025 will convene on Thursday, 20 November 2025 in London, held in conjunction with the Jefferies London Healthcare Conference. With four successful iterations in San Francisco and London, the Forum has established itself as a premier gathering for top minds in cell and gene therapy.Under the theme THE NEXT ERA OF CGT IS HERE, we are honored to invite leading experts from academia, industry, investment, and regulatory agencies to discuss the latest advancements in research, technological breakthroughs and evolving regulatory landscapes. This forum will bring together global thought leaders united in the mission to accelerate therapies that improve patient lives.(2) Hot TopicsNAVIGATING THE FUTURE OF CELL THERAPY: EVALUATING VARIED PATHWAYS IN CELL THERAPY INNOVATION FOR COMPREHENSIVE SECTOR INSIGHTSLATEST PROGRESS AND FUTURE OUTLOOK IN GENE THERAPY AND MRNAFROM LAB TO PATIENT: OVERCOMING CMC BARRIERS IN CELL AND GENE THERAPY MANUFACTURINGINNOVATION AND INVESTMENT FOR CGT ​(3) Schedule: (GMT Time Zone)• Registration: 12:00 P.M.-1:30 P.M.• Program: 1:30 P.M.- 6:30 P.M.• Reception: 6:30 P.M.- 8:00 P.M.(4) Part of Confirmed SpeakersDima Al-hadithi, Founder and Director of Minaret Consulting Limited and RareGenix Consulting LimitedMichael Brinkman, Managing Director and Joint US Head of Biopharmaceuticals Investment Banking, JefferiesMichel Broker,Managing Director and Global Head of Pharma, UBSLuigi Calzolai, Scientific Officer, European Commission Joint Research Centre (JRC）Anna Cereseto, Head of Lab for Advanced Genome Editing Technologies, University of Trento, Co-Founder, Alia TherapeuticsMatthieu Coutet, Partner, Sofinnova Biovelocita StrategyDaniela Couto, General Partner at BioGeneration VenturesJonathan Esensten, Senior Advisor, Multiply Labs, and Director, Advanced Biotherapy Center, Sheba Medical CenterMiguel Forte, President and Board of Directors Chair of the International Society of Cell and Gene Therapy (ISCT)Miroslav Gasparek, CEO and Co-founder, Sensible BiotechnologiesMarten Hansen, Head of the Laboratory for Cell Therapy at the Sanquin Blood Supply Foundation, CEO of the Amsterdam Cell Therapy Center, Secretary of the Dutch-Flemish ATMP Working PartyStephen Hansen, Director of Biopharma Intelligence, BioCenturyYing Huang, CEO, Legend BiotechCarl June, Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine, Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine, Director of the Parker Institute for Cancer Immunotherapy, University of PennsylvaniaPeter Jones, Director, Pengwin ConsultancySergio Linares, Ph.D, Unit Head of RNA Science Automation, SanofiHongbo Lu, Founder and Managing Partner of NextBio CapitalJohn Maher, Scientific Founder and Chief Scientific Officer, Leucid BioMarcello Maresca, Senior Director of Genome Engineering department, AstraZenecaCraig Mello, Blais University Chair in Molecular Medicine, and co-director of the RNA Therapeutics Institute at the University of Massachusetts Medical School, 2006 Nobel Prize in Physiology or MedicineJulen Oyarzabal, CSO of Syngoi Technologies SLPaula Río, Head of the Bone Marrow Aplasia Unit at CIEMAT/CIBERER/IIS-FJDRobin Shattock, Chair in Mucosal Infection and Immunity, Imperial College LondonPaul Stoffels, Former Chief Scientific Officer, Johnson &amp; Johnson. Co-founder, Former CEO - Chair Galapagos NVLaura Stoppel, Partner on the Investment Team, RA Capital ManagementJin Yin, PhD, CTO of CGT Technology Center, ProBioWe would like to extend to you a cordial invitation to join your peers at what promises to be a unique opportunity to share insights and collaborate on the global advancement of cell and gene therapy in London in November 2025.*Program schedule and speakers are subject to change.Highlights of Series Forumhttps://www.youtube.com/watch?v=SQWpdfuWUbA&amp;ab_channel=RSBUGenScript
- **Event URL**: https://allevents.in/london/genscript-biotech-global-forum-london-2025/100001563879669189
- **Event Categories**: business, parties, entertainment, conferences
- **Interested Audience**: 
  - total_interested_count: 0

## Ticket Details

- **Ticket URL**: https://consumer.pxf.io/c/1339408/3151484/39691?partnerpropertyid=1191892&MediaPartnerPropertyId=1191892&svlink=14105511&level=1&u=https%3A%2F%2Fwww.eventbrite.com%2Fe%2Fgenscript-biotech-global-forum-london-2025-tickets-1563879669189
- **Ticket Price Range**: min: 50, max: 50, currency: GBP

## Event venue details

- **city**: London
- **state**: EN
- **country**: United Kingdom
- **location**: THE NASH ROOM- 116 Pall Mall
- **lat**: 51.5072564
- **long**: -0.1319063
- **full address**: THE NASH ROOM- 116 Pall Mall, 116 Pall Mall, London, United Kingdom

## Event Organizer details

- **affiliate_id**: 10
- **organizer**: GenScript Biotech Corporation (https://allevents.in/org/genscript-biotech-corporation/18317148)

## Event gallery

- **Alt text**: banner
  - **Image URL**: https://cdn-az.allevents.in/events7/banners/41dfff3cc9de161f21ab7a33fc0e4008efcdaa933140707cb20faeef987fcab6-rimg-w1200-h600-dc72c2ab-gmir.jpg?v=1759751668
- **Alt text**: thumbnail
  - **Image URL**: https://cdn-az.allevents.in/events7/banners/1079e24f26bc8af08df7f57918d6154b0d72bc97692c6034b47799c8bcc4acba-rimg-w400-h400-dc61a6a9-gmir.jpg?v=1759751667

## FAQs

- **Q**: When is the event happening?
  - **A:** Thu, 20 Nov, 2025 at 01:30 pm
- **Q**: Where is the event happening?
  - **A:** THE NASH ROOM- 116 Pall Mall, 116 Pall Mall, London, United Kingdom
- **Q**: What is the ticket price?
  - **A:** starting from 50 up to 50 GBP
- **Q**: Who is organizing the event?
  - **A:** GenScript Biotech Corporation
- **Q**: What type of event is this?
  - **A:** business, parties, entertainment, conferences
- **Q**: Where can I find ticket details about GenScript Biotech Global Forum London 2025 ?
  - **A:** You can find ticket details about this event on AllEvents.

## Structured Data (JSON-LD)

```json
[
    {
        "@context": "https://schema.org",
        "@type": "Event",
        "name": "GenScript Biotech Global Forum London 2025",
        "image": "https://cdn-az.allevents.in/events7/banners/41dfff3cc9de161f21ab7a33fc0e4008efcdaa933140707cb20faeef987fcab6-rimg-w1200-h600-dc72c2ab-gmir.jpg?v=1759751668",
        "startDate": "2025-11-20",
        "endDate": "2025-11-20",
        "url": "https://allevents.in/london/genscript-biotech-global-forum-london-2025/100001563879669189",
        "location": {
            "@type": "Place",
            "name": "THE NASH ROOM- 116 Pall Mall",
            "address": {
                "@type": "PostalAddress",
                "streetAddress": "116 Pall Mall",
                "postalCode": "SW1Y 5ED",
                "addressLocality": "London",
                "addressRegion": "EN",
                "addressCountry": "GB"
            },
            "geo": {
                "@type": "GeoCoordinates",
                "latitude": "51.5072564",
                "longitude": "-0.1319063"
            }
        },
        "eventAttendanceMode": "https://schema.org/OfflineEventAttendanceMode",
        "description": "The Forum unites CGT leaders to turn breakthroughs into patient value, bridging science, industry, and capital markets.",
        "offers": [
            {
                "@type": "AggregateOffer",
                "availability": "https://schema.org/InStock",
                "priceCurrency": "GBP",
                "availabilityStarts": "2026-03-24",
                "availabilityEnds": "2025-11-20",
                "validFrom": "2026-03-24",
                "lowPrice": "50.00",
                "highPrice": "50.00",
                "price": "50.00",
                "url": "https://allevents.in/london/genscript-biotech-global-forum-london-2025/100001563879669189"
            },
            {
                "@type": "Offer",
                "availability": "https://schema.org/InStock",
                "priceCurrency": "GBP",
                "availabilityStarts": "2026-03-24",
                "availabilityEnds": "",
                "validFrom": "2026-03-24",
                "url": "https://allevents.in/london/genscript-biotech-global-forum-london-2025/100001563879669189",
                "price": "50.00",
                "name": "Pre-registration"
            }
        ],
        "organizer": [
            {
                "@type": "Organization",
                "name": "GenScript Biotech Corporation",
                "url": "https://allevents.in/org/genscript-biotech-corporation/18317148",
                "description": "GenScript Biotech Corporation (Stock Code: 1548.HK) is a global biotechnology group. Built upon its leading gene synthesis technology, GenScript is divided into four major platforms including the life science contract research organization (CRO) platform, the biologics contract development and manufacturing organization (CDMO) platform, the global cell therapy platform, and the industrial synthesis biological product platform.\rGenScript was founded in New Jersey, US in 2002 and listed on the Hong Kong Stock Exchange in 2015. GenScript's business operations span over 100 countries and regions worldwide with legal entities located in the US, Mainland China, Hong Kong, China, Japan, Singapore, the Netherlands and Ireland. GenScript provides premium, convenient, and reliable products and services for over 100,000 customers.\rAs of June 30, 2020, GenScript had more than 3,900 employees globally, over 36% of whom hold master’s and/or Ph.D. degrees. In addition, GenScript owns a number of intellectual property rights and trade secrets, including more than 140 patents and over 450 pending patent applications. \rDriven by the corporate mission of “making people and nature healthier through biotechnology”, GenScript strives to become the most trustworthy biotech company in the world. As of June 30, 2020, GenScript's products or services have been cited by 51,000 peer-reviewed journal articles worldwide.\rFor more information, visit GenScript's official website https://www.genscript.com.\r"
            }
        ]
    }
]
```